• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ORISE GEL; SUBMUCOSAL INJECTION AGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ORISE GEL; SUBMUCOSAL INJECTION AGENT Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Granuloma (1876); Perforation (2001)
Event Date 05/01/2023
Event Type  Injury  
Event Description
It was reported to boston scientific corporation that orise gel was used to lift a polyp in the cecum during an endoscopic submucosal dissection (esd) in (b)(6) 2022.During the procedure, approximately 4-6 ml of orise gel was injected into the patient's cecum to resect a polyp.It was noted the patient's stomach was insufflating and the physician observed a perforation in the patient's hepatic flexure, away from the lesion site.The perforation was treated with a clip, however, the physician felt uncomfortable finishing the esd due to the perforation and the procedure was rescheduled.The patient returned sometime in 2023 to complete the esd procedure.The physician remarked that the orise gel he had injected previously in (b)(6) 2022 and left unresected did make it challenging for him to complete the esd during the follow-up procedure, and some deformation caused by orise under the lesion was observed.It is unknown what caused the perforation; however, it was noted by the physician that it was procedural related and not device related.
 
Manufacturer Narrative
Block b3: the exact date of the event is unknown.The provided event date was chosen as a best estimate based on the date that the manufacturer became aware of the event.Block d4 and h4: the complainant was unable to provide the suspect device upn and lot number; therefore, the lot expiration and device manufacture dates are unknown.Block h6: patient code (b)(6): perforation is being used to capture the reportable event of a procedure-related perforation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORISE GEL
Type of Device
SUBMUCOSAL INJECTION AGENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC LIMITED
model farm road
cork
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key17075749
MDR Text Key316747914
Report Number3005099803-2023-02868
Device Sequence Number1
Product Code PLL
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial
Report Date 06/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/12/2023
Initial Date FDA Received06/06/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction Number92970101-FA
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-